| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |